Acute hepatitisB17.8

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Acute viral hepatitis; hepatitis epidemica; Hepatitis infectious

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Virus-induced acute diffuse inflammation of the liver.

ClassificationThis section has been translated automatically.

  • Infectious hepatitis (hepatitis epidemica)
  • Serum hepatitis (transfusion hepatitis, syringe hepatitis).

Clinical featuresThis section has been translated automatically.

  • Hepatitis A: incubation period 6-50 days (average 32 days).
  • Hepatitis B: Incubation period up to 160 days.
  • Hepatitis C: Possible occurrence of vasculitis.

TherapyThis section has been translated automatically.

Bed rest, diet, avoidance of hepatotoxic drugs and alcohol; in the case of fulminant progressions with liver failure, intensive care measures.

Progression/forecastThis section has been translated automatically.

TablesThis section has been translated automatically.

Virus

Abbreviation/Synonym

Genetic information

Family

Occurrence/Epidemiology

Transmission

History

hepatitis A

HAV

RNA

Picornaviruses

depending on age, antibodies are detectable in 5-70% of the population

fecal-oral

acute

hepatitis B

HBV

DNA

Hepadnaviruses

approx. 50,000 new infections per year

Blood, sexual, perinatal

acute, fulminant, chronic (in 1-10% of cases)

Antibodies detectable in 5-20% of the population (vaccination, past illness)

hepatitis C

HCV

RNA

Flaviviruses

5-10,000 new infections per year (higher number of unreported cases); 200,000-350,000 infected persons nationwide

Blood, sexual, perinatal

acute, fulminant, chronic (in approx. 10-20% of cases)

hepatitis D

HDV

RNA

HBV-Satellite

very rare; superinfection with HBV infection often causes severe chronic courses (> 70%) with high lethality

Blood, sexual, perinatal

acute, fulminant, chronic

hepatitis E

HEV

RNA

Caliciviruses

Endemic in India, former CIS states, West Africa. In tropical and subtropical countries HEV is responsible for more than 50% of acute cases.

fecal-oral

acute, fulminant (especially for pregnant women)

hepatitis G

HGV

RNA

Flaviviruses

Coinfection in 80% of all injecting drug users infected with hepatitis C; antibodies are detectable in about 1% of the population worldwide

Blood, sexual

asymptomatic

Authors

Last updated on: 29.10.2020